Successful treatment of lower eyelid melanoma in situ.

Gassman, Andrew A; Yuan, Joyce; Koh, Justin; Miller, Timothy A

Gassman, Andrew A; Yuan, Joyce; Koh, Justin; Miller, Timothy A.

Afiliación

Gassman AA; Division of Plastic and Reconstructive Surgery, Department of Surgery, UCLA David Geffen School of Medicine, Los Angeles, Calif.; and UCLA David Geffen School of Medicine, Los Angeles, Calif.
Yuan J; Division of Plastic and Reconstructive Surgery, Department of Surgery, UCLA David Geffen School of Medicine, Los Angeles, Calif.; and UCLA David Geffen School of Medicine, Los Angeles, Calif.
Koh J; Division of Plastic and Reconstructive Surgery, Department of Surgery, UCLA David Geffen School of Medicine, Los Angeles, Calif.; and UCLA David Geffen School of Medicine, Los Angeles, Calif.
Miller TA; Division of Plastic and Reconstructive Surgery, Department of Surgery, UCLA David Geffen School of Medicine, Los Angeles, Calif.; and UCLA David Geffen School of Medicine, Los Angeles, Calif.

Plast Reconstr Surg Glob Open ; 2(5): e154, 2014 May.

Article en En | MEDLINE | ID: mdl-25289347

RESUMEN

SUMMARY: We present a brief literature review of the topical immune-modulating medication Imiquimod. The treatment of periorbital melanoma in situ typically requires surgical resection. Here we discuss a case of lower eyelid melanoma in situ successfully treated non-operatively with Imiquimod.

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Plast Reconstr Surg Glob Open Año: 2014 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google